Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Costa

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|August 18, 2009
Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantationB R Adams, A N Miller, L J Costa
Bone Marrow Transplantation|September 12, 2012
Tandem autologous vs autologous plus reduced intensity allogeneic transplantation in the upfront management of multiple myeloma: meta-analysis of trials with biological assignmentK E Armeson, E G Hill, L J Costa
Leukemia|February 13, 2015
Early mortality in multiple myelomaL J Costa, W I Gonsalves, S K Kumar
Virology|March 8, 2000
Generation of intersubtype human immunodeficiency virus type 1 recombinants in env gene in vitro: influences in the biological behavior and in the establishment of productive infectionsL J Costa, P Munerato, R S Diaz, et al.
Brazilian Dental Journal|January 1, 1994
Human papilloma virus--its association with epithelial proliferative lesionsL J Costa, F R Silveira, J M Batista, et al.
Antiviral Therapy|March 7, 2002
Antiretroviral treatment failure and HIV-1 genotypic resistance in Sao Paulo, BrazilM C Sucupira, I E Souza, L J Costa, et al.
Bone Marrow Transplantation|June 3, 2014
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal doseK B dos Santos, L J Costa, A Atalla, et al.
Bone Marrow Transplantation|April 13, 2010
Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilizationL J Costa, E T Alexander, K R Hogan, et al.
Bone Marrow Transplantation|January 16, 2008
Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantationL J Costa, I N Micallef, D J Inwards, et al.
Bone Marrow Transplantation|July 13, 2010
Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilizationL J Costa, A N Miller, E T Alexander, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|August 18, 2009
Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantationB R Adams, A N Miller, L J Costa
Bone Marrow Transplantation|September 12, 2012
Tandem autologous vs autologous plus reduced intensity allogeneic transplantation in the upfront management of multiple myeloma: meta-analysis of trials with biological assignmentK E Armeson, E G Hill, L J Costa
Leukemia|February 13, 2015
Early mortality in multiple myelomaL J Costa, W I Gonsalves, S K Kumar
Virology|March 8, 2000
Generation of intersubtype human immunodeficiency virus type 1 recombinants in env gene in vitro: influences in the biological behavior and in the establishment of productive infectionsL J Costa, P Munerato, R S Diaz, et al.
Brazilian Dental Journal|January 1, 1994
Human papilloma virus--its association with epithelial proliferative lesionsL J Costa, F R Silveira, J M Batista, et al.
Antiviral Therapy|March 7, 2002
Antiretroviral treatment failure and HIV-1 genotypic resistance in Sao Paulo, BrazilM C Sucupira, I E Souza, L J Costa, et al.
Bone Marrow Transplantation|June 3, 2014
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal doseK B dos Santos, L J Costa, A Atalla, et al.
Bone Marrow Transplantation|April 13, 2010
Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilizationL J Costa, E T Alexander, K R Hogan, et al.
Bone Marrow Transplantation|January 16, 2008
Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantationL J Costa, I N Micallef, D J Inwards, et al.
Bone Marrow Transplantation|July 13, 2010
Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilizationL J Costa, A N Miller, E T Alexander, et al.
Pageof 3